Latest News and Press Releases
Want to stay updated on the latest news?
-
Delårsrapport januari-september 2009 Pressmeddelande 2009-11-27 Väsentliga händelser under tredje kvartalet - Rörelseresultatet uppgick till - 1 864 SEK...
-
Decision of the Market Services Department (27-11-2009, Minutes No.210) To remove a surveillance status for the following company: Dvarcioniu Keramika ORS (LT0000122319 DKR1L) 26-11-2009 is...
-
Viktiga händelser under verksamhetsåret - Inkludering av barn från tio års ålder och accelererad patientrekrytering påbörjades i amerikansk fas III-studie med diabetesvaccinet Diamyd®. - Första...
-
Oslo, Norway, 27 November 2009. As part of the share buyback program, Photocure has on 26 November 2009 bought 37,900 shares in Photocure ASA with an average price of NOK 48.89 per share. The...
-
Stockholm, Sweden November 27, 2009 - Biovitrum AB (publ) (STO:BVT) today announced an agreement with Amgen to expand Biovitrum's Kineret license to include certain orphan indications. The...
-
Stockholm, 27 november 2009 - Biovitrum AB (publ) (STO: BVT) meddelade i dag att man träffat avtal med Amgen om att utvidga Biovitrums licens för Kineret till att omfatta indikationer för...
-
Getupdated Internet Marketing AB (publ): Delårsrapport januari - september 2009 Genomgripande strukturarbete, sänkta kostnader och stabiliserad försäljning Tredje kvartalet 2009 •...
-
Diamyd Medical's Annual Report for 2008/2009 is from today available in Swedish on the company website, www.diamyd.com. A printed Annual Report can be...
-
Indre værdi for Alm. Brand Formue A/S. ...
-
The ChronVac-C® study has been successfully completed with good safety and favorable clinical data All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep's...